Evidence map›Paper›PMID 37983005›Full record

ArticleDiscover mental health2023

Immunoglobulin G is a natural oxytocin carrier which modulates oxytocin receptor signaling: relevance to aggressive behavior in humans.

Henning Værøy, Emilie Lahaye, Christophe Dubessy, Magalie Benard, Marion Nicol, Yamina Cherifi, Saloua Takhlidjt, Jean-Luc do Rego, Jean-Claude do Rego, Nicolas Chartrel and 1 more

Open access · goldAbstract read
In one paragraph

Article in Discover mental health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Navigating Central Oxytocin Transport: Known Realms and Uncharted Territories.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2025
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Henning Værøy *Department of Psychiatric Research, Akershus University Hospital, 1478, Nordbyhagen, Norway. Henning.Vaeroy@ahus.no.
Emilie Lahaye *INSERM 1239, Neuroendocrine, Endocrine and Germinal Differentiation and Communication Laboratory, University of Rouen Normandie, 76000, Rouen, France.
Christophe DubessyINSERM 1239, Neuroendocrine, Endocrine and Germinal Differentiation and Communication Laboratory, University of Rouen Normandie, 76000, Rouen, France.
Magalie BenardINSERM US51, CNRS UAR 2026, Imagine Platform PRIMACEN- HeRacLeS, Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen Normandie, 76000, Rouen, France.
Marion NicolINSERM 1239, Neuroendocrine, Endocrine and Germinal Differentiation and Communication Laboratory, University of Rouen Normandie, 76000, Rouen, France.
Yamina CherifiINSERM 1239, Neuroendocrine, Endocrine and Germinal Differentiation and Communication Laboratory, University of Rouen Normandie, 76000, Rouen, France.
Saloua TakhlidjtINSERM 1239, Neuroendocrine, Endocrine and Germinal Differentiation and Communication Laboratory, University of Rouen Normandie, 76000, Rouen, France.
Jean-Luc do RegoINSERM US51, CNRS UAR 2026, Behavioral Analysis Platform SCAC-HeRacLeS, Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen Normandie, 76000, Rouen, France.
Jean-Claude do RegoINSERM US51, CNRS UAR 2026, Behavioral Analysis Platform SCAC-HeRacLeS, Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen Normandie, 76000, Rouen, France.
Nicolas ChartrelINSERM 1239, Neuroendocrine, Endocrine and Germinal Differentiation and Communication Laboratory, University of Rouen Normandie, 76000, Rouen, France.
Sergueï O FetissovINSERM 1239, Neuroendocrine, Endocrine and Germinal Differentiation and Communication Laboratory, University of Rouen Normandie, 76000, Rouen, France. Serguei.Fetissov@univ-rouen.fr.
Inserm · FRUniversité de Rouen Normandie · FRAkershus University Hospital · NOCentre National de la Recherche Scientifique · FRInstitute for Research and Innovation in Biomedicine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxytocin is a neuropeptide produced mainly in the hypothalamus and secreted in the CNS and blood. In the brain, it plays a major role in promoting social interactions. Here we show that in human plasma about 60% of oxytocin is naturally bound to IgG which modulates oxytocin receptor signaling. Further, we found that IgG of violent aggressive inmates were characterized by lower affinity for oxytocin, causing decreased oxytocin carrier capacity and reduced receptor activation as compared to men from the general population. Moreover, peripheral administration of oxytocin together with human oxytocin-reactive IgG to resident mice in a resident-intruder test, reduced c-fos activation in several brain regions involved in the regulation of aggressive/defensive behavior correlating with the attack number and duration. We conclude that IgG is a natural oxytocin carrier protein modulating oxytocin receptor signaling which can be relevant to the biological mechanisms of aggressive behavior.

Indexed as

Aggressive behaviorAutoantibodiesBrainc-fosHumanIntracellular signalingMiceNeuroendocrinologyNeuropeptidesOxytocinOxytocin receptor

Identifiers

PMID37983005
PMCPMC10587035
OpenAlexW4387780386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.